Lung Cancers Today spoke with Dr. Ofer Sharon, CEO of OncoHost, to discuss the lack of dependable pre-treatment biomarkers for predicting irAE development and how OncoHost is spearheading the efforts to address this issue.
Watch here.
Lung Cancers Today spoke with Dr. Ofer Sharon, CEO of OncoHost, to discuss the lack of dependable pre-treatment biomarkers for predicting irAE development and how OncoHost is spearheading the efforts to address this issue.
Watch here.
![[Nanomedic in MedTech Insight] Start-Up Snapshot: Nanomedic’s Electro-Spinning, Portable Wound Care Device](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
